Tamoxifen 20 - Advar Pharma

Tamoxifen citrate, known for its dual agonist and antagonist properties, was first synthesized in 1962 and later marketed under Nolvadex by AstraZeneca. Its primary medical application is in the treatment of breast cancer, targeting estrogen receptors to inhibit tumor growth. In the athletic community, tamoxifen is widely used to prevent estrogenic effects such as gynecomastia during steroid cycles. Furthermore, it can positively influence cholesterol levels through partial estrogenic activity in the liver, making it a preferred option over aromatase inhibitors for some users .

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Tamoxifen 20 by Advar Pharma, consult with your doctor or healthcare professional.